BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.02
Delayed Data
As of Feb 23
 +0.22 / +4.58%
Today’s Change
3.95
Today|||52-Week Range
9.25
+2.24%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close4.80
Today’s open4.87
Day’s range4.73 - 5.04
Volume870,553
Average volume (3 months)1,211,585
Market cap$494.0M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+5.71%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book234.69

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...+0.83+5.16%
CYADCelyad SA-0.98-2.38%
SELBSelecta Biosciences ...+0.29+3.35%
NSTGNanoString Technolog...+0.06+0.88%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts